ÖGPP 2014: Das biopsychosoziale Modell am Beispiel der Psychohepatologie

1 Baranyi A et al., Interferon-α bei Patienten mit chronischer Hepatitis C. Nervenarzt 2012; 83:1169–77

2 Baranyi A et al., Auswirkungen depressiver Symptome auf die gesundheitsbezogene Lebensqualität, die sexuelle Zufriedenheit und die kognitive Leistungsfähigkeit bei Patienten nach orthotoper Lebertransplantation. Neuropsychiatr 2012; 26:59–64

3 Baranyi A et al., A biopsychosocial model of interferon-alpha-induced depression in patients with chronic hepatitis C infection. Psychother Psychosom 2013; 82:332–40

4 Steiner J et al., Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission? J Neuroinflammation 2011; 8:94

5 Baranyi A et al., Asymmetric Dimethylarginine responses during Interferon-α-induced depression in patients with chronic hepatitis C infection. Psychosom Med 2014; [Epub ahead of print]

6 Miyazaki H et al., Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis. Circulation 1999; 99:1141–6

7 Baranyi A et al., Psychische Belastungssymptome und gesundheits­bezogene Lebensqualität bei Patienten nach orthotoper Lebertrans­plantation. Z Psychosom Med Psychother 2012; 58:417–28

8 Rothenhäusler HB et al., Psychiatric and psychosocial outcome of ortho­topic liver transplantation. Psychother Psychosom 2002; 71:285–97

9 Baranyi A et al., Posttraumatic stress symptoms after solid-organ transplantation: preoperative risk factors and the impact on health-related quality of life and life satisfaction. Health Qual Life Outcomes 2013; 11:111

10 Baranyi A, Krauseneck T, Rothenhäusler HB, Overall mental distress and health-related quality of life after solid-organ transplantation: results from a retrospective follow-up study. Health Qual Life Outcomes 2013; 11:15